Forecast & Rating11 analysts currently cover SAB Biotherapeutics, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $11.64, about 207.0% upside from the current price of $3.79. Price targets range from $6.00 to $16.00 — a wide spread, showing clear disagreement over just how much SAB Biotherapeutics can rise. For you, this means most professionals who study SAB Biotherapeutics closely still see room for the stock to rise. Data as of Aug 10, 2026; for reference only and not investment advice.
Aug 10, 2026Price forecast
$11.64207.03%
Forecast & RatingStrong buy
11analysts
- Strong buy90.91%
- Buy9.09%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 23, 2026
Forecast met0.0%
Stock price$3.79
Avg. target$9.7
High target$15
Low target$5
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.